Responding to defenses of the PhilHealth fund transfer
The third tranche of the controversial P89.9 billion in Philippine Health Insurance Corp. (PhilHealth) “unused” funds, worth P30 billion, is...
The third tranche of the controversial P89.9 billion in Philippine Health Insurance Corp. (PhilHealth) “unused” funds, worth P30 billion, is...
BW FILE PHOTO By Aaron Michael C. Sy, Reporter RATES of Treasury bills (T-bills) and Treasury bonds (T-bonds) on offer...
BW FILE PHOTO THE Philippine peso would likely be range-bound against the dollar this week, analysts said, as the market...
REUTERS By Revin Mikhael D. Ochave, Reporter PHILIPPINE STOCKS could sustain their climb on dovish policy forecasts and a more...
UN PHOTO MANILA’s top envoy in his speech before the United Nations General Assembly (UNGA) pushed for the peaceful and...
By Kenneth Christiane L. Basilio, Reporter THE HOUSE of Representatives may have violated a Philippine Constitution provision disallowing amendments on...
By John Victor D. Ordoñez, Reporter LIQUEFIED natural gas (LNG) is a viable transition fuel to clean energy but may...
By Kyle Aristophere T. Atienza, Reporter THE Philippine liberal opposition is open to working with left-leaning opposition forces such as...
THE Commission on Audit (CoA) has flagged the municipal government of Balabagan, Lanao del Sur for failing to submit its...
Copyright © 2025 InvestDailyPro. All Rights Reserved.
Disclaimer: InvestDailyPro.com, its managers, its employees, and assigns (collectively InvestDailyPro ) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice.
The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.